10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Charles De Vaulx's Top Third Quarter Stocks

Monica Wolfe

Monica Wolfe

133 followers
Charles De Vaulx of the IVA Funds reported his third quarter holdings this past week. In October the IVA Funds celebrated their fifth year in the business. The fund maintains a dual investment approach which is split into short- and long-term investments. IVA reports that their short-term (12 to 18 months) investments are in order to preserve capital while their longer term (5 to 10 years) they try to perform better that their equity benchmark. The fund also reported that over the past five years, they achieved both of these goals with their investments.

Over the past quarter Charles De Vaulx in his IVA Worldwide Fund bought nine new stocks bringing the total number of stocks to 102 valued at $4.858 billion. The following five companies are De Vaulx’s largest holdings as of the close of the third quarter.

Nestle SA (XSWX:NESN)

De Vaulx’s largest position over the past quarter was in Nestle SA where he holds on to 4,220,716 shares of the company’s stocks. His holdings make up for 6.1% of his total portfolio and 0.13% of the company’s shares outstanding.

During the third quarter De Vaulx upped his holdings 48.55% by purchasing a total of 1,379,455 shares of the company’s stock. The guru bought these shares in the price range of CHF60.60 to CHF65.05, with an estimated average quarterly price of CHF62.58. Since then the price per share has increased approximately 5.9%.

Charles De Vaulx’s historical holding history:

1385591484983.png

Nestle SA manufactures and markets food products. The Company's product line includes milk, chocolate, confectionery, creamer, coffee, food seasoning, bottled water and pet foods among others.

Nestle’s historical revenue and net income:

1385589309939.png

The analysis on the company reports that the revenue has been in decline over the past five years, the company has issued CHF6.3 billion of debt over the past year, the operating margin is expanding and P/E and P/B ratios are nearing 1-year lows.

Top guru shareholders of Nestle:

1. David Herro: 7,209,000 shares, representing a 0.22% stake and 2.2% of his total portfolio.

2. Charles de Vaulx: 4,220,716 shares, representing a 0.13% stake and 6.1% of his total portfolio.

3. Tweedy Brown: 2,781,120 shares, representing a 0.09% stake and 3.4% of their total assets.

The Peter Lynch Chart suggests that the company is currently overvalued:

1385589329191.png

Nestle SA has a market cap of CHF213.64 billion. Its shares are currently trading at around CHF66.25 with a P/E ratio of 20.10, a P/S ratio of 2.24 and a P/B ratio of 3.44. The company had an annual average earnings growth of 4.80%.

Astellas Pharma (TSE:4503)

The guru’s second largest holding is in Astellas Pharma where he holds on to 5,095,800 shares of the company’s stock. His holdings make up for 5.3% of his total portfolio and 1.16% of the company’s shares outstanding.

De Vaulx did not alter his position in the company over the last quarter. The guru last sold shares in the second quarter of 2012 and since then the price per share is up about 11.1%.

De Vaulx’s holding history as of the third quarter:

1385591773159.png

Astellas Pharma Inc is engaged in the business of manufacturing, marketing and import/export of pharmaceuticals. The company's businesses are segmented into pharmaceutical and other.

Astellas Pharma’s historical revenue and net income:

1385589561601.png

The analysis on Astellas Pharma reports that the company’s price is sitting near a 5-year high, its dividend yield is near a 5-year low and the company currently holds no debt.

The top guru shareholders of Astellas Pharma:

1. Vanguard Health: 14,365,700 shares, representing 3.26% of the company’s shares outstanding and 2.5% of their total portfolio.

2. Charles de Vaulx: 5,095,800 shares, representing 1.16% of the company’s shares outstanding and 5.3% of his total portfolio.

3. IVA International Fund: 1,986,500 shares, representing 0.45% of the company’s shares outstanding and 5.6% of their total assets managed.

The Peter Lynch Chart suggests that the company is currently overvalued:

1385589580807.png

Astellas Pharma has a market cap of ¥2623.45 billion. Its shares are currently trading at around ¥5960.00 with a P/E ratio of 52.80, a P/S ratio of 2.49 and a P/B ratio of 0.59. The company currently holds a dividend yield of around 2%.

Devon Energy (DVN)

De Vaulx’s third largest position is in Devon Energy where he holds on to 4,088,040 shares of the company’s stock. His holdings make up for 4.9% of his total portfolio and 1.01% of the company’s shares outstanding.

De Vaulx did not alter his position in the company over the past quarter. From his last buy in the second quarter the price per share has gone up about 8.7%.

De Vaulx’s historical holding history:

1385592116964.png

Devon Energy is an independent energy company engaged mainly in the exploration, development and production of oil, natural gas and NGLs. The company's operations are concentrated in various North American onshore areas in the U.S. and Canada.

Devon’s historical revenue and earnings growth:

1385589994281.png

The top guru shareholders of Devon Energy:

1. Jean-Marie Eveillard: 7,908,819 shares, representing 1.95% of the company’s shares outstanding and 1.3% of his total portfolio.

2. Tweedy Browne: 4,229,160 shares, representing 1.04% of the company’s shares outstanding and 5.9% of his total portfolio.

3. Charles de Vaulx: 4,088,040 shares, representing 1.01% of the company’s shares outstanding and 4.6% of his total portfolio.

The analysis on Devon Energy reports that the company’s price is nearing a 1-year high, its revenue has been in decline for the past five years and it has issued $4.5 billion of debt over the past three years.

Devon Energy has a market cap of $24.59 billion. Its shares are currently trading at around $60.57 with a P/E ratio of 32.80, a P/S ratio of 2.40 and a P/B ratio of 1.20. The company has a 1.40% dividend yield.

Berkshire Hathaway (BRK.A)

The guru’s fourth largest holding goes to Berkshire Hathaway where he maintains 1,339 shares of the company’s stock. His position makes up for 4.7% of his total assets managed and 0.08% of the company’s shares outstanding.

Over the duration of the last quarter De Vaulx cut his holdings -13.95% by selling a total of 217 shares of Berkshire stock. He sold these shares in the price range of $167,050 to $178,275, with an estimated average quarterly price of $173,021 per share. Since then the price per share has gone up a slight 0.9%.

De Vaulx’s historical holding history:

1385592516593.png

Berkshire Hathaway is a conglomerate holding company owning subsidiaries engaged in a number of business activities, including property and casualty insurance and reinsurance, utilities and energy, finance, manufacturing, service and retailing.

Berkshire Hathaway’s historical revenue and earnings growth:

1385590328322.png

The analysis on Berkshire Hathaway reports that the company’s price is near a 10-year high, it has shown predictable revenue and earnings growth and its operating margin is expanding.

The top guru shareholders of BRK.A:

1. Chris Davis: 11,367 shares, representing 0.69% of the company’s shares outstanding and 5% of his total portfolio.

2. Ruane Cunniff: 10,710 shares, representing 0.65% of the company’s shares outstanding and 10.8% of his total portfolio.

3. Tom Russo: 4,953 shares, representing 0.3% of the company’s shares outstanding and 9% of his total assets managed.

The Peter Lynch Chart suggests that the company is currently overvalued:

1385590401711.png

Berkshire Hathaway has a market cap of $285.7 billion. Its shares are currently trading at around $174,625 with a P/E ratio of 14.60, a P/S ratio of 1.60 and a P/B ratio of 1.30. Berkshire Hathaway had an annual average earnings growth of 6.80% over the past ten years.

GuruFocus rated Berkshire Hathaway the business predictability rank of 2.5-star.

Oracle (ORCL)

The guru’s fifth largest holding goes to Oracle where he maintains 5,687,640 shares of the company’s stock. His position makes up for 3.9% of his total portfolio.

The guru did not alter his position in Oracle over the duration of the past quarter, but since his sell in the second quarter the price per share is up about 6.4%.

De Vaulx’s holding history of Oracle as of the third quarter:

1385592801262.png

Oracle provides technologies of cloud computing, including database and middleware as well as web-based applications, virtualization, clustering and systems management. It provides cloud services as well as software and hardware products to other cloud service providers, both public and private.

Oracle’s historical revenue and net income:

1385591034470.png

The analysis on Oracle reports that the company’s revenue has slowed down over the past year, its price is near a 10-year high, its operating margin is expanding and its dividend yield is also near a 5-year high.

The top guru shareholders of Oracle:

1. Jeremy Grantham: 49,441,015 shares, representing 1.07% of the company’s shares outstanding and 4.3% his total portfolio.

2. Jean-Marie Eveillard: 27,367,792 shares, representing 0.59% of the company’s shares outstanding and 2.6% of his total portfolio.

3. Donald Yacktman: 24,416,925 shares, representing 0.53% of the company’s shares outstanding and 3.6% of his total portfolio.

The Peter Lynch Chart suggests that the company is currently undervalued:

1385591072523.png

Oracle Corporation has a market cap of $160.83 billion. Its shares are currently trading at around $35.29 with a P/E ratio of 15.30, a P/S ratio of 4.50 and a P/B ratio of 3.70. The company had an annual average earnings growth of 19.00% over the past ten years.

GuruFocus rated Oracle the business predictability rank of 4.5-star.

Check out Charles De Vaulx’s full third quarter portfolio here.

Try a 7-day premium membership trial here.

Rating: 4.0/5 (1 vote)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK